BridgeBio Pharma, Inc. Quarterly Current Ratio in % from Q2 2020 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: BridgeBio Pharma, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q2 2024.
BridgeBio Pharma, Inc. Current Ratio for the quarter ending June 30, 2024 was 469 %, a 3.65% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	469	-17.7	-3.65%	Jun 30, 2024
Q1 2024	455	-70.8	-13.5%	Mar 31, 2024
Q4 2023	449	-103	-18.6%	Dec 31, 2023
Q3 2023	489	-116	-19.2%	Sep 30, 2023
Q2 2023	487	-148	-23.3%	Jun 30, 2023
Q1 2023	526	-151	-22.3%	Mar 31, 2023
Q4 2022	552	-188	-25.4%	Dec 31, 2022
Q3 2022	605	-145	-19.4%	Sep 30, 2022
Q2 2022	634	-181	-22.2%	Jun 30, 2022
Q1 2022	677	-214	-24%	Mar 31, 2022
Q4 2021	740	-226	-23.4%	Dec 31, 2021
Q3 2021	750	-306	-28.9%	Sep 30, 2021
Q2 2021	815	-315	-27.9%	Jun 30, 2021
Q1 2021	891			Mar 31, 2021
Q4 2020	965			Dec 31, 2020
Q3 2020	1.06K			Sep 30, 2020
Q2 2020	1.13K			Jun 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.